CStone Pharmaceuticals Share Price Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
08:55:01 11/09/2026 BST
|
After hours 21:03:02 | |||
| 0.6158 EUR | -5.87% |
|
0.6336 | +2.89% |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 08-31 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
| Market Cap | 7.89B 1.18B 1.01B 959M 869M 1.63B 112B 1.64B 11.39B 4.38B 57.15B 4.42B 4.32B 181B | P/E 2026 * |
-17.1x | P/E 2027 * | 8.29x |
|---|---|---|---|---|---|
| Enterprise Value | 6.91B 1.03B 888M 840M 762M 1.43B 98.41B 1.44B 9.98B 3.84B 50.07B 3.87B 3.78B 158B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | 2.24x |
| Free-Float |
79.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript : CStone Pharmaceuticals
| 1 day | -5.87% | ||
| 1 week | -7.12% | ||
| Current month | +0.88% | ||
| 1 month | +8.68% | ||
| 3 months | +34.78% | ||
| 6 months | -17.89% | ||
| Current year | +8.04% |
| 1 week | 0.62 |  | 0.67 |
| 1 month | 0.55 | | 0.74 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.45 | | 1.12 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.35 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 24/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 17/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 31/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 24/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 08/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.87% | -7.12% | - | - | 1.24B | |
| -1.48% | -7.35% | +40.60% | -5.92% | 79.21B | |
| -1.42% | -4.79% | -20.78% | -38.31% | 58.22B | |
| +5.38% | -3.29% | +492.23% | +33.75% | 54.54B | |
| -0.56% | -4.20% | -11.00% | +27.11% | 48.89B | |
| +1.93% | -6.84% | -1.34% | +149.15% | 44.72B | |
| +0.80% | -3.28% | +52.27% | -16.16% | 31.83B | |
| -1.47% | -5.10% | +40.83% | +89.86% | 24.99B | |
| -0.85% | -8.82% | -6.07% | +164.64% | 20.95B | |
| -0.09% | -4.70% | +62.73% | +102.03% | 15.8B | |
| Average | -0.32% | -5.31% | +72.16% | +56.24% | 42.13B | |
| Weighted average by Cap. | +0.36% | -5.38% | +83.88% | +36.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.08M 54.35M 51.46M 46.64M 87.5M 6.03B 87.95M 611M 235M 3.07B 237M 232M 9.69B | 1.72B 257M 221M 209M 190M 356M 24.53B 358M 2.49B 957M 12.48B 964M 943M 39.43B |
| Net income | -384M -57.17M -49.26M -46.64M -42.28M -79.31M -5.46B -79.71M -554M -213M -2.78B -215M -210M -8.78B | 680M 101M 87.39M 82.75M 75M 141M 9.69B 141M 983M 378M 4.93B 381M 373M 15.58B |
| Net Debt | -978M -146M -126M -119M -108M -202M -13.92B -203M -1.41B -543M -7.08B -547M -535M -22.38B | -4.02B -600M -517M -489M -443M -832M -57.29B -836M -5.81B -2.23B -29.14B -2.25B -2.2B -92.09B |
| Date | Price | Change |
|---|---|---|
| 11/09/26 | €0.6158 | -5.87% |
| 10/09/26 | €0.6542 | +0.49% |
| 09/09/26 | €0.6510 | -1.45% |
| 08/09/26 | €0.6606 | +2.17% |
| 07/09/26 | €0.6466 | -13.21% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
